TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 14752668

Group type: EXPERIMENTAL
Intervention: HRCT (+) patients
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: HRCT (−) patients
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both HRCT (+) and HRCT (−) patients
Number of subjects: 29
Study: 11348938

Group type: EXPERIMENTAL
Intervention: Inhaled formoterol dry powder, 12 microg bid, in addition to ipratropium bromide, 40 microg qid for 3 weeks
Number of subjects: 172

Group type: COMPARATOR
Intervention: Salbutamol, 200 microg qid, in addition to ipratropium, 40 microg qid for 3 weeks
Number of subjects: 172
Study: 9212293

Group type: EXPERIMENTAL
Intervention: Soluble ibuprofen 400 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 8484645

Group type: EXPERIMENTAL
Intervention: Raja pleural biopsy needle
Number of subjects: 31

Group type: COMPARATOR
Intervention: Abrams pleural biopsy needle
Number of subjects: 31
Study: 3326116

Group type: EXPERIMENTAL
Intervention: Zopiclone (7.5 mg)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Nitrazepam (5 mg)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 30610875

Group type: EXPERIMENTAL
Intervention: online HD‐atDCS
Number of subjects: 9

Group type: COMPARATOR
Intervention: offline HD‐atDCS
Number of subjects: 9

Group type: COMPARATOR
Intervention: sham
Number of subjects: 9
Study: 26310877

Group type: EXPERIMENTAL
Intervention: High-dose nicotine dermal patches (n=90)
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Low-dose nicotine dermal patches (n=132)
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Bupropion (n=65)
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: First-generation antipsychotics (n=129)
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Preparation stage (n=97)
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Contemplation stage (n=70)
Number of subjects: 287
Study: 25367823

Group type: EXPERIMENTAL
Intervention: Composite intervention consisting of education on recommended GWG according to IOM, application of personalised weight graph, formalised prescription of exercise and regular monitoring of GWG at every antenatal visit.
Number of subjects: 445

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: Composite intervention
Number of subjects: 445
Study: 23551662

Group type: EXPERIMENTAL
Intervention: Low-level light therapy (LLLT) device
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham device
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Investigator global assessment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Subject global assessment
Number of subjects: 40
Study: 21481712

Group type: EXPERIMENTAL
Intervention: Cranberry juice (480 mL/day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (480 mL/day)
Number of subjects: 16
Study: 19461217

Group type: EXPERIMENTAL
Intervention: Testosterone enanthate (250 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 16831439

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate plus N-acetyl cysteine (50 mg twice per day and 1200 mg/d for 5 days)
Number of subjects: 804

Group type: COMPARATOR
Intervention: Clomiphene citrate alone (with sugar powder)
Number of subjects: 804
Study: 15105515

Group type: EXPERIMENTAL
Intervention: Supervised high-intensity progressive resistance training (PRT) for 12 weeks
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Supervised high-intensity progressive resistance training (PRT)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Upper extremity stretching (Control)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Performance-based measures of function (both groups)
Number of subjects: 42
Study: 12032753

Group type: EXPERIMENTAL
Intervention: Walking
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (dietary counselling only)
Number of subjects: 90
Study: 9579625

Group type: EXPERIMENTAL
Intervention: 1-stage full-mouth disinfection (scaling and root planing of all pockets within 24 hours, application of chlorhexidine to all intra-oral niches, chlorhexidine mouth rinsing for 2 months)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Fractionated periodontal therapy (consecutive root planings per quadrant at a 1 to 2 week interval)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both treatment groups (1-stage full-mouth disinfection and fractionated periodontal therapy)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 1-stage full-mouth disinfection
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 1-stage full-mouth disinfection and fractionated periodontal therapy
Number of subjects: 24
Study: 8573224

Group type: EXPERIMENTAL
Intervention: Celiprolol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 12
Study: 2764538

Group type: EXPERIMENTAL
Intervention: Single-dose enoxacin (600 mg)
Number of subjects: 154

Group type: COMPARATOR
Intervention: 3-day treatment with enoxacin (200 mg twice a day)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Follow-up at 4 to 6 weeks
Number of subjects: 154
Study: 793563

Group type: EXPERIMENTAL
Intervention: Methylphenidate hydrochloride (double-blind trial)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Stimulants or tricyclic antidepressants (open trial)
Number of subjects: 15
Study: 31212860

Group type: EXPERIMENTAL
Intervention: Green Space (GS) exposure
Number of subjects: 263

Group type: COMPARATOR
Intervention: Randomized Controlled Trials (RCTs)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Qualitative subjective research
Number of subjects: 263
Study: 28640436

Group type: EXPERIMENTAL
Intervention: Two-step irradiance schedule
Number of subjects: 141

Group type: COMPARATOR
Intervention: Single-dose cold compress
Number of subjects: 141
Study: 25853746

Group type: EXPERIMENTAL
Intervention: Leukocyte-reduced red cells stored for 10 days or less (shorter-term storage group)
Number of subjects: 1098

Group type: EXPERIMENTAL
Intervention: Leukocyte-reduced red cells stored for 21 days or more (longer-term storage group)
Number of subjects: 1098
Study: 23128421

Group type: EXPERIMENTAL
Intervention: Morphine (0.3 mg/kg)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Rapid Sequence Induction (RSI) with thiopental 2‐3 mg/kg and remifentanil 1 mcg/kg
Number of subjects: 34
Study: 21767799

Group type: EXPERIMENTAL
Intervention: Open benchmark quality circles (B-QC)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Traditional anonymous feedback quality circles (T-QC)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Both B-QC and T-QC
Number of subjects: 96
Study: 19815485

Group type: EXPERIMENTAL
Intervention: PC-SPES 960 mg t.i.d.
Number of subjects: 38

Group type: COMPARATOR
Intervention: DES 3 mg/day
Number of subjects: 38
Study: 16707874

Group type: EXPERIMENTAL
Intervention: AmF/SnF2 mouthwash after brushing
Number of subjects: 30

Group type: COMPARATOR
Intervention: Omitting the post-brush water rinse
Number of subjects: 30
Study: 14985223

Group type: EXPERIMENTAL
Intervention: Iron supplementation (daily supervised iron for 12 weeks)
Number of subjects: 523

Group type: COMPARATOR
Intervention: Placebo iron (control group)
Number of subjects: 523
Study: 11028575

Group type: COMPARATOR
Intervention: Traditional care
Number of subjects: 609

Group type: EXPERIMENTAL
Intervention: Flexible care
Number of subjects: 609
Study: 8831157

Group type: EXPERIMENTAL
Intervention: Measured positive and negative bases of attitudes (Study 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manipulated positive and negative bases of attitudes (Studies 2 and 3)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conflicting reactions (positive or negative)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dominant reactions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Threshold of conflicting reactions
Number of subjects: 0
Study: 1317133

Group type: EXPERIMENTAL
Intervention: Fluoxetine (up to 80 mg po daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 6328685

Group type: EXPERIMENTAL
Intervention: ranitidine (Zantac)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Gelusil (antacid preparation)
Number of subjects: 88
Study: 31322451

Group type: EXPERIMENTAL
Intervention: Trivalent seasonal influenza vaccine (TIV)
Number of subjects: 1569

Group type: COMPARATOR
Intervention: Control group (non-vaccinated)
Number of subjects: 1569
Study: 27423649

Group type: EXPERIMENTAL
Intervention: Motion-tracking method of laparoscopic instruments using an optical pose tracker
Number of subjects: 44
Study: 26048455

Group type: EXPERIMENTAL
Intervention: Bicalutamide 50mg plus dutasteride 3.5mg once daily for 18 months
Number of subjects: 127

Group type: COMPARATOR
Intervention: Bicalutamide 50mg plus placebo
Number of subjects: 127
Study: 23362889

Group type: EXPERIMENTAL
Intervention: LMA ProSeal
Number of subjects: 116

Group type: COMPARATOR
Intervention: Endotracheal Tube (ETT)
Number of subjects: 116
Study: 21742541

Group type: EXPERIMENTAL
Intervention: Unilateral zygopophyseal joint posteroanterior mobilisation
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Static posterior chain muscle stretch
Number of subjects: 36

Group type: COMPARATOR
Intervention: Non-treatment control
Number of subjects: 36
Study: 20025366

Group type: EXPERIMENTAL
Intervention: Group motivational enhancement therapy (GMET)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Focus on Alcohol Concerns (FAC) education group
Number of subjects: 206

Group type: COMPARATOR
Intervention: Alcohol information-only control group (AI)
Number of subjects: 206
Study: 16431255

Group type: EXPERIMENTAL
Intervention: Paricalcitol
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study: 16324162

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 162

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162
Study: 11057792

Group type: EXPERIMENTAL
Intervention: Protocol group (19 patients) treated to maintain 'supranormal' values of oxygen delivery
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (18 patients) treated to maintain normal values of oxygen delivery
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (18 patients)
Number of subjects: 37
Study: 9390988

Group type: EXPERIMENTAL
Intervention: Conventional resistance training plus head‐extension exercise (ResX group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conventional resistance training only
Number of subjects: 0

Group type: COMPARATOR
Intervention: No resistance exercise (Control group)
Number of subjects: 0
Study: 1589079

Group type: EXPERIMENTAL
Intervention: Isoflurane anesthesia (forane)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Neuroleptanalgesia (NLA)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 35
Study: 3897471

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with Adriamycin for six months
Number of subjects: 156

Group type: COMPARATOR
Intervention: No further treatment (control group)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Pelvic irradiation (optional before randomization)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Specific cell types (leiomyosarcoma, homologous mixed mesodermal sarcoma, heterologous mixed mesodermal sarcoma)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with Adriamycin
Number of subjects: 156
Study: 3277485

Group type: EXPERIMENTAL
Intervention: Lorazepam 0.06 mg/kg po 90 min preoperatively
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Morphine 0.1 mg/kg im plus scopolamine 0.006 mg/kg im 60 min preoperatively
Number of subjects: 42
Study: 31584517

Group type: EXPERIMENTAL
Intervention: Treatment-naive group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Previous treatment group
Number of subjects: 0
Study: 29775166

Group type: EXPERIMENTAL
Intervention: Aluminum foot insole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control foot insole
Number of subjects: 0
Study: 28630338

Group type: EXPERIMENTAL
Intervention: Values affirmation intervention
Number of subjects: 0
Study: 26047319

Group type: EXPERIMENTAL
Intervention: Minor allele (C) of rs3212227 in IL12(p40)
Number of subjects: 1729

Group type: EXPERIMENTAL
Intervention: Minor allele (A) of rs4073 in IL8
Number of subjects: 1729

Group type: EXPERIMENTAL
Intervention: Minor alleles of IL10 tagSNPs rs1800890 (A)
Number of subjects: 1729

Group type: EXPERIMENTAL
Intervention: Minor allele of IL10 tagSNP rs3021094 (C)
Number of subjects: 1729
Study: 24172064

Group type: EXPERIMENTAL
Intervention: Gain-frame messages
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Loss-frame messages
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Intention to immunize during pregnancy
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Viewing the film 'Contagion'
Number of subjects: 261

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 261
Study: 21173438

Group type: EXPERIMENTAL
Intervention: Joint evaluation of risk information formats (ARR, RRR, POL)
Number of subjects: 895

Group type: EXPERIMENTAL
Intervention: Separate evaluation of risk information formats (ARR, RRR, POL)
Number of subjects: 895

Group type: EXPERIMENTAL
Intervention: Separate evaluation of NNT
Number of subjects: 895

Group type: EXPERIMENTAL
Intervention: Evaluability bias for risk information formats
Number of subjects: 895
Study: 18332075

Group type: EXPERIMENTAL
Intervention: Lactobacillus GG (5 x 10(9) colony-forming units twice daily)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Lactobacillus GG
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Lactobacillus GG and Placebo
Number of subjects: 105
Study: 17000820

Group type: EXPERIMENTAL
Intervention: Aspirin gargle (350 mg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Benzydamine hydrochloride gargle (15 mL, 0.15%)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Mineral water (Control)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Aspirin and benzydamine hydrochloride gargles
Number of subjects: 60
Study: 14681960

Group type: EXPERIMENTAL
Intervention: Eprosartan mesilat (600 mg daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Other hypotensive medicines (control group)
Number of subjects: 20
Study: 10763795

Group type: COMPARATOR
Intervention: Vinyl flooring
Number of subjects: 54

Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Additional leg strengthening exercises
Number of subjects: 54
Study: 8630590

Group type: EXPERIMENTAL
Intervention: Salmeterol 50 micrograms twice daily
Number of subjects: 738

Group type: EXPERIMENTAL
Intervention: Salmeterol 100 micrograms twice daily
Number of subjects: 738

Group type: COMPARATOR
Intervention: Beclomethasone dipropionate 1,000 micrograms twice daily
Number of subjects: 738
Study: 1361423

Group type: EXPERIMENTAL
Intervention: co‐trimoxazole for 3 days
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: co‐trimoxazole for 7 days
Number of subjects: 117
Study: 6428170

Group type: EXPERIMENTAL
Intervention: Verapamil (360 mg/d)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Propranolol (180 mg/d)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 31014469

Group type: EXPERIMENTAL
Intervention: Moderate alcohol intake (0.6 g/kg)
Number of subjects: 38
Study: 29462230

Group type: EXPERIMENTAL
Intervention: Oxymetazoline cream 0.5%, 1.0%, or 1.5% applied topically once or twice daily for 28 days
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: Oxymetazoline cream 1.5% applied twice daily
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: Oxymetazoline cream 1.5% applied once daily
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: Oxymetazoline cream (all concentrations)
Number of subjects: 356

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 356
Study: 27107460

Group type: EXPERIMENTAL
Intervention: Ceftazidime-avibactam (2000 mg ceftazidime plus 500 mg avibactam, administered via a 2-h intravenous infusion every 8 h for 5-21 days)
Number of subjects: 333

Group type: COMPARATOR
Intervention: Best available therapy (mostly carbapenems, 163 (97%) of 168 patients received a carbapenem, 161 (96%) as monotherapy)
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Ceftazidime-avibactam
Number of subjects: 333

Group type: COMPARATOR
Intervention: Best available therapy
Number of subjects: 333
Study: 25185131

Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 65

Group type: COMPARATOR
Intervention: Midodrine
Number of subjects: 65
Study: 22784612

Group type: EXPERIMENTAL
Intervention: Uzara® Lösung N (ULN)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Digoxin (1 mg, i.v.)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 20440121

Group type: EXPERIMENTAL
Intervention: Paired Set (PS) training
Number of subjects: 16

Group type: COMPARATOR
Intervention: Traditional Set (TS) training
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both PS and TS training
Number of subjects: 16
Study: 18326972

Group type: EXPERIMENTAL
Intervention: RASI/verapamil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RASI/HCTZ to RASI/verapamil
Number of subjects: 0
Study: 16307689

Group type: EXPERIMENTAL
Intervention: Tadalafil 10 mg
Number of subjects: 2099

Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg
Number of subjects: 2099

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2099
Study: 11907741

Group type: EXPERIMENTAL
Intervention: Lidocaine administration immediately prior to TACE (group A, n = 30)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Lidocaine administration immediately after TACE (group B, n = 46)
Number of subjects: 113

Group type: COMPARATOR
Intervention: No lidocaine administration (group C, n = 37)
Number of subjects: 113
Study: 9972047

Group type: EXPERIMENTAL
Intervention: Antiparasitic treatment (after two weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Trichinella spiralis infection (before treatment)
Number of subjects: 40
Study: 7992349

Group type: EXPERIMENTAL
Intervention: Oral iron supplementation (200 mg ferrous sulphate daily)
Number of subjects: 0
Study: 2738211

Group type: EXPERIMENTAL
Intervention: Motivated condition
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nonmotivated condition
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Depressed group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nondepressed group
Number of subjects: 60
Study: 30481760

Group type: EXPERIMENTAL
Intervention: Immediate Cord Clamping (ICC)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Delayed Cord Clamping (DCC) for 30-60 s
Number of subjects: 101
Study: 27846366

Group type: EXPERIMENTAL
Intervention: Interactive video gaming (IVG) using Nintendo Wii, 45 min per day, 6 days a week for 3 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional therapy alone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Interactive video gaming (IVG) using Nintendo Wii
Number of subjects: 20
Study: 25874510

Group type: EXPERIMENTAL
Intervention: 2 days of octreotide infusion (50 μg/kg)
Number of subjects: 124

Group type: COMPARATOR
Intervention: 5 days of octreotide infusion (50 μg/kg)
Number of subjects: 124
Study: 23837630

Group type: EXPERIMENTAL
Intervention: Liberal red blood cell (RBC) transfusion policy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Restrictive red blood cell (RBC) transfusion policy
Number of subjects: 0
Study: 21823284

Group type: EXPERIMENTAL
Intervention: Electroacupuncture plus acupoint injection with Methylcobalamin (group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Acupoint injection with Methylcobalamin (group B)
Number of subjects: 60
Study: 19861283

Group type: EXPERIMENTAL
Intervention: Defibrase therapy (intravenous infusion at doses of 15, 10, and 5 U based on plasma FIB levels)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Defibrase therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 60
Study: 17559450

Group type: EXPERIMENTAL
Intervention: Conventional method with local anaesthesia
Number of subjects: 299

Group type: COMPARATOR
Intervention: Conventional method without local anaesthesia
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment (ART) with local anaesthesia
Number of subjects: 299

Group type: COMPARATOR
Intervention: Atraumatic restorative treatment (ART) without local anaesthesia
Number of subjects: 299
Study: 15768820

Group type: EXPERIMENTAL
Intervention: hylan B gel (n =47)
Number of subjects: 70

Group type: COMPARATOR
Intervention: collagen (n =23)
Number of subjects: 70
Study: 11454146

Group type: EXPERIMENTAL
Intervention: GLP-1 administered at the onset of a standard meal (550 kCal)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: GLP-1 administered at 30 min after the start of the meal
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: GLP-1 administered at 60 min after the start of the meal
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control meal
Number of subjects: 8
Study: 9491969

Group type: EXPERIMENTAL
Intervention: Oxaprozin (1200 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Urine oxaprozin standards
Number of subjects: 12
Study: 7487368

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Nonsteroid antiinflammatory drugs (NSAID)
Number of subjects: 79
Study: 2725277

Group type: EXPERIMENTAL
Intervention: Trilostane 240 mg/d (Trilo 240)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Trilostane 60 mg/d (Trilo 60)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 29939279

Group type: EXPERIMENTAL
Intervention: Anakinra (100 mg subcutaneously twice daily for 4 weeks)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 28954789

Group type: EXPERIMENTAL
Intervention: HeLP-Diabetes (web-based self-management programme)
Number of subjects: 374

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 374
Study: 26078237

Group type: EXPERIMENTAL
Intervention: Enteral nutrition with monitoring of gastric residual volume (GRV)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Enteral nutrition without monitoring of gastric residual volume (GRV)
Number of subjects: 210
Study: 23250341

Group type: EXPERIMENTAL
Intervention: Methylergonovine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Oxytocin
Number of subjects: 80